A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers

Autor: Monif, Tausif, Rao Thudi, Nageshwar, Koundinya Tippabhotla, Sudhakar, Khuroo, Arshad, Marwah, Amit, Kumar Shrivastav, Vikesh, Tandon, Monika, Raghuvanshi, Rajeev, Biswal, Shibadas
Zdroj: In Clinical Therapeutics 2007 29(12):2677-2684
Databáze: ScienceDirect